They found that RIC ameliorated the post-stroke reduction of peripheral blood CD3(+)CD8(+) T cells and CD3(+)/CD161a(+) NKT cells markedly, and robustly increased the percentage of CD43(+)/CD172a(+) non-inflammatory monocytes. The gene discussed is SPN; the disease is stroke disorder.